Analyst Research

Report Title Price
Rigas farmaceitiska fabrika AS: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Rigas Farmaceitiska Fabrika AS (FRM1R) - Financial Analysis Review
Provider: GlobalData
$125.00
Buy
Rigas Farmaceitiska Fabrika AS (FRM1R) - Financial Analysis Review
Provider: GlobalData
$125.00
Buy
Rigas Farmaceitiska Fabrika AS (FRM1R) - Financial Analysis Review
Provider: GlobalData
$75.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Rigas Farmaceitiska Fabrika AS Appoints SIA ABrevizija as Auditor


Monday, 25 Feb 2013 03:30am EST 

Rigas Farmaceitiska Fabrika AS announced that it has decided, at its Extraordinary Shareholder's Meeting, to appoint SIA ABrevizija as the Company’s auditor for the financial year 2012. 

Latest Developments for Rigas farmaceitiska fabrika AS

Latest Key Developments in Pharmaceuticals

Company Quote

Rigas farmaceitiska fabrika AS
(FRM1R.RI)
0.672
0.0010 +0.15%
23 May 2013